Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress

Status unconfirmed · Phase 4

Conditions studied: Coronary Artery Disease

In brief

Lexiscan(TM) has ideal properties for Rb-82 PET imaging and the stress response it invokes may offer multiple advantages for the diagnosis of coronary disease and functional abnormalities. The goal of this investigation is to establish quantitative equivalence of Lexiscan(TM) rest/stress Rb-82 PET images to dipyridamole rest/stress images.

Key facts

Study ID

NCT00808314

Run by

Cardiovascular Imaging Technologies

People needed

32

Starts

2008-12-01

Expected to finish

2012-09-01

Last updated by the study team

2012-08-02

Who can join

Age: 35 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI <35
• No intervention or change in management between dipyridamole and Lexiscan(TM) PET

You may not qualify if…

• BMI >35
• An intervention or change in management between dipyridamole and Lexiscan(TM) PET

Where it is running

• Saint Luke's Cardiovascular Consultants — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.